Liver Cirrhosis, Biliary Clinical Trial
Official title:
Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)
Primary biliary cirrhosis (PBC) is a disease of the liver, which predominantly affects women. It causes slowly progressive liver disease, which eventually causes liver failure, requiring a liver transplant. Several different studies of large patient cohorts indicate that the cause of this disease is likely due to a combination of factors including genetic and environmental. PBC is associated with several other "autoimmune diseases" - recently a gene has been identified to be abnormal in individuals with another autoimmune liver disease, namely rheumatoid arthritis. This gene usually tells the body when to switch off an immune response. This study plans to identify whether individuals diagnosed with PBC have a similar abnormality in this gene called protein Tyrosine Phosphatase.
Very recently, a single nucleotide polymorphism (SNP) in the PTPN22 gene encoding the Lyp (lymphoid-specific phosphatase) PTP has been shown to be associated with susceptibility to rheumatoid arthritis (RA) and Type 1 diabetes (T1D)4,5. These data are consistent with the known role for Lyp in suppressing T cell activation and with data showing T cell activation (and potentially autoreactivity) to be increased by the RA and T1D-associated PTPN22 variant. The PTPN22 risk allele has also been recently implicated in Grave’s disease and as such appears to represent a susceptibility allele for many autoimmune diseases. As a number of these conditions (RA, T1D etc.) frequently occur within members of PBC families, this PTPN22 variant is very likely to also be involved in PBC, a possibility we will directly investigate in this pilot study. The aim of this study is to analyze the frequency of a specific PTPN22 polymorphism in patients with PBC. ;
Observational Model: Defined Population, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02917408 -
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
|
||
Terminated |
NCT00550862 -
Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
|
Phase 2 | |
Completed |
NCT00004748 -
Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis
|
Phase 3 | |
Completed |
NCT03630718 -
Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women
|
N/A | |
Completed |
NCT00004842 -
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
|
Phase 1 | |
Terminated |
NCT03633227 -
Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment
|
Phase 4 | |
Terminated |
NCT00125281 -
SAMe to Treat Biliary Cirrhosis Symptoms
|
Phase 2 | |
Completed |
NCT04629456 -
Physical Therapy for Liver Cirrhosis
|
N/A | |
Completed |
NCT03468699 -
Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia
|
Phase 2 | |
Completed |
NCT00006168 -
Ursodiol-Methotrexate for Primary Biliary Cirrhosis
|
Phase 3 | |
Completed |
NCT00004784 -
Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis
|
Phase 3 | |
Completed |
NCT00570765 -
Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
|
Phase 2 | |
Recruiting |
NCT00160940 -
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
|
N/A | |
Recruiting |
NCT03146910 -
Swiss Primary Biliary Cholangitis Cohort Study
|
||
Terminated |
NCT03265249 -
BRIDGE Device for Post-operative Pain Control
|
N/A | |
Terminated |
NCT02308111 -
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
|
Phase 4 | |
Recruiting |
NCT02936596 -
Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
|
N/A | |
Completed |
NCT00406237 -
Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis
|
Phase 1 | |
Completed |
NCT04047160 -
Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
|
Phase 1 | |
Terminated |
NCT03476993 -
Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis
|
Phase 2 |